Search research articles
Contact Us
Filters
Showing results (161-170 of 170) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 170 results.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2016
Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting
Stéphane Bouchet, Sylvie Poulette, Karine Titier, et al.
BMJ Open
|
July 3, 2020
Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study
Carey Meredith Suehs, Maéva Zysman, Cécile Chenivesse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 9, 2017
Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study
Alain Ravaud, Carlos Gomez-Roca, Marie-Quitterie Picat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2010
Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib
David Marin, Alexandra Bazeos, Francois-Xavier Mahon, et al.
Therapie
|
August 8, 2014
Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situations
Mathieu Molimard, Corine Bernaud, Philippe Lechat, et al.
Therapie
|
July 10, 2016
[Not Available]
Mathieu Molimard, Corine Bernaud, Philippe Lechat, et al.
Fundamental & Clinical Pharmacology
|
May 13, 2020
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic
Louis Larrouquere, Manon Gabin, Emmanuelle Poingt, et al.
British Journal of Haematology
|
July 1, 2021
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients
Philippe Rousselot, Luigina Mollica, Joëlle Guilhot, et al.
Pharmaceutics
|
August 26, 2022
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia
Hyacinthe Johnson-Ansah, Benjamin Maneglier, Françoise Huguet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 19, 2022
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)
Alexandre Duvignaud, Edouard Lhomme, Racha Onaisi, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 170) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 170 results.
European Journal of Cancer (Oxford, England : 1990)
|
February 7, 2016
Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting
Stéphane Bouchet, Sylvie Poulette, Karine Titier, et al.
BMJ Open
|
July 3, 2020
Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study
Carey Meredith Suehs, Maéva Zysman, Cécile Chenivesse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 9, 2017
Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study
Alain Ravaud, Carlos Gomez-Roca, Marie-Quitterie Picat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2010
Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib
David Marin, Alexandra Bazeos, Francois-Xavier Mahon, et al.
Therapie
|
August 8, 2014
Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situations
Mathieu Molimard, Corine Bernaud, Philippe Lechat, et al.
Therapie
|
July 10, 2016
[Not Available]
Mathieu Molimard, Corine Bernaud, Philippe Lechat, et al.
Fundamental & Clinical Pharmacology
|
May 13, 2020
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic
Louis Larrouquere, Manon Gabin, Emmanuelle Poingt, et al.
British Journal of Haematology
|
July 1, 2021
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients
Philippe Rousselot, Luigina Mollica, Joëlle Guilhot, et al.
Pharmaceutics
|
August 26, 2022
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia
Hyacinthe Johnson-Ansah, Benjamin Maneglier, Françoise Huguet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 19, 2022
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)
Alexandre Duvignaud, Edouard Lhomme, Racha Onaisi, et al.
Page
of 17